Skip to content
Clinical Trials – home

Intestinal obstruction Treatment

0 / 1 trials open to patients1 country

In short

When the intestines become blocked, food and fluids cannot move through the digestive system as they should. This serious medical condition requires prompt attention to prevent dangerous complications and, in many cases, demands specialized treatment approaches tailored to each patient's unique situation.

Key points

  • Intestinal obstruction is a medical emergency requiring immediate hospital care—symptoms like inability to pass gas or stool combined with severe pain should never be ignored
  • Most partial obstructions (65-81%) resolve with conservative treatment within 72 hours using IV fluids and nasogastric tube decompression
  • Surgery is typically not the first option—doctors wait up to 3 days to see if conservative treatment works unless there are signs of serious complications
  • Adhesions from previous abdominal surgery cause most small bowel obstructions, while tumors and volvulus commonly cause large bowel blockages
  • Antibiotics are routinely given even without infection signs because blocked intestines allow bacteria to potentially enter the bloodstream
  • Water-soluble contrast studies serve double duty—they help diagnose obstruction location and may actually help resolve partial blockages therapeutically
  • The timing of surgery matters: prolonging conservative treatment beyond 72 hours without improvement increases surgical complications without improving outcomes
  • Prevention strategies after previous obstruction include dietary modifications like eating smaller meals, chewing thoroughly, and limiting high-fiber foods

Managing a Blockage: Treatment Goals and Approaches

The treatment of intestinal obstruction focuses on several critical goals: relieving the blockage itself, restoring normal digestive function, preventing serious complications such as tissue death or perforation, and addressing the underlying cause when possible. Every approach must be carefully chosen based on where the blockage is located—whether in the small intestine or large intestine—and whether the blockage is partial or complete. The patient's overall health, medical history, and the severity of symptoms all play important roles in deciding the best course of action.

Medical professionals rely on established treatment protocols approved by surgical and gastroenterological societies worldwide. These standard approaches have been refined over many years and focus on stabilizing the patient first, then addressing the blockage through conservative measures whenever possible. At the same time, researchers continue exploring new therapeutic methods in clinical trials, seeking ways to improve outcomes and reduce the need for invasive surgery.

Time is a critical factor in treating intestinal obstruction. Healthcare providers must balance the benefits of waiting to see if conservative treatment works against the risk of complications that can develop if a blockage persists. Most blockages require hospitalization, where patients can be closely monitored and receive immediate intervention if their condition worsens. The treatment pathway typically begins with supportive care and progresses to more invasive options only when necessary.

Standard Treatment: The Foundation of Care

When someone arrives at the hospital with a suspected intestinal obstruction, the first priority is stabilizing their condition. This means addressing the immediate problems caused by the blockage: dehydration, electrolyte imbalances, and the buildup of pressure in the digestive tract. Patients typically cannot eat or drink anything by mouth, as this would add more material to an already backed-up system. Instead, they receive intravenous fluids—fluids delivered directly into a vein through a small tube—to maintain hydration and restore the body's chemical balance.

A key component of standard treatment is bowel decompression, which means removing the built-up gas and fluids from the digestive system to relieve pressure and pain. Doctors accomplish this by inserting a thin, flexible tube called a nasogastric tube or NG tube through the patient's nose, down the throat, and into the stomach. This tube allows trapped gas and fluids to drain out, which can provide significant relief from nausea, vomiting, and abdominal distension. While the tube is uncomfortable, it plays a vital role in allowing the bowel to rest and potentially resolve the blockage on its own.

For partial small bowel obstructions—cases where some material can still pass through—conservative treatment with intravenous fluids and nasogastric decompression succeeds in approximately 65 to 81 percent of cases. Most patients who will improve with this approach do so within 72 hours. Medical guidelines recommend that if there are no signs of serious complications like strangulation (where blood supply to the bowel is cut off) or perforation (a hole in the bowel wall), doctors can safely continue conservative management for up to three days.

Doctors also prescribe medications to manage symptoms and prevent complications. Pain medications help control discomfort, though physicians carefully avoid drugs like opioids that can slow intestinal movement and potentially worsen the obstruction. Antiemetic medications help reduce nausea and vomiting. Importantly, antibiotics are often given even to patients who show no signs of infection. This is because when the intestine is obstructed, bacteria that normally live harmlessly in the gut can multiply excessively and potentially cross through the damaged intestinal wall into the bloodstream, causing dangerous infections. Antibiotics help prevent this bacterial translocation.

In some cases, doctors use a diagnostic and therapeutic tool called water-soluble contrast medium. The patient swallows this special liquid, and X-rays track how it moves through the digestive system. If the contrast reaches the large intestine within four hours, this strongly predicts that conservative treatment will be successful. Interestingly, the contrast itself may help resolve partial obstructions by drawing water into the intestine and stimulating movement.

For large bowel obstructions, particularly those caused by twisting of the colon called volvulus, doctors may attempt a procedure called colonoscopy with decompression. During this procedure, a flexible tube with a camera is inserted through the rectum and advanced into the colon to untwist the bowel or release trapped gas. In some cases, doctors place a mesh tube called a stent inside the narrowed area to hold it open and allow waste to pass through. These approaches can provide temporary or sometimes permanent relief without surgery.

Surgery becomes necessary when conservative treatment fails after 48 to 72 hours, or immediately if there are signs of serious complications. Studies show that prolonging conservative management beyond this window does not improve outcomes but does increase surgical complications if surgery ultimately becomes necessary. During surgery, the surgeon identifies and removes or repairs the cause of the obstruction. This might involve cutting away scar tissue adhesions, repairing a hernia, removing a tumor, or in severe cases, removing damaged sections of the intestine.

When intestinal tissue has died due to lack of blood supply, the surgeon must remove that section entirely. In these situations, patients may need a temporary or permanent ostomy—a surgical opening in the abdominal wall where a healthy portion of the intestine is brought to the surface. Waste then exits the body through this opening into a disposable bag that attaches to the skin. In some cases, after the patient recovers, surgeons can reverse the ostomy and reconnect the intestine, but in other situations, particularly when extensive disease is present, the ostomy may be permanent.

The typical hospital stay for intestinal obstruction managed conservatively ranges from several days to a week or more, depending on how quickly the blockage resolves. Patients remain on bowel rest—not eating or drinking—until their intestines begin functioning normally again, which doctors confirm by listening for bowel sounds with a stethoscope and observing whether the patient can pass gas. When recovery begins, patients start with clear liquids, then gradually progress to soft foods before returning to a regular diet. Those who require surgery may need longer hospital stays and have a more extended recovery period at home.

Treatment in Clinical Trials: Exploring New Approaches

While standard treatments for intestinal obstruction are well-established, researchers continue investigating new methods to improve outcomes and reduce the need for surgery. Clinical trials explore innovative approaches, though specific details about investigational drugs or therapies for intestinal obstruction are limited in the current medical literature. Most research in this area focuses on preventing recurrent obstructions rather than treating acute episodes.

One area of ongoing investigation involves materials that can prevent adhesions—the bands of scar tissue that form after abdominal surgery and are the leading cause of small bowel obstruction. Studies have examined substances like hyaluronic acid-carboxymethylcellulose membranes and icodextrin solution. These materials are applied during surgery to create a temporary barrier between healing tissues, potentially reducing the formation of adhesions. Research suggests that icodextrin may reduce the risk of future bowel obstructions in patients who have had abdominal surgery, though these substances cannot treat an obstruction once it occurs.

Another focus of clinical research is prokinetic medications—drugs that stimulate intestinal movement. For patients with chronic intestinal pseudo-obstruction, a condition where the intestine behaves as if blocked even when no physical obstruction exists, researchers have tested various medications that enhance the coordinated muscle contractions needed for normal digestion. These drugs work on different receptors or chemical messengers in the intestinal nervous system. While some show promise in small studies for chronic conditions, their role in treating acute mechanical obstruction remains limited.

Researchers are also exploring less invasive surgical techniques through clinical trials. Laparoscopic surgery, where surgeons operate through small incisions using specialized instruments and a camera, is being studied as an alternative to traditional open surgery for selected patients with intestinal obstruction. The 2013 World Society of Emergency Surgery guidelines recommend laparoscopic approaches in appropriate patients, particularly those without signs of strangulation. These minimally invasive techniques may reduce recovery time, decrease post-operative pain, and potentially lower the risk of future adhesions compared to traditional open surgery, though they require specialized equipment and surgical expertise.

Some research focuses on better predicting which patients will respond to conservative treatment and which will need surgery. Clinical trials have examined various blood tests, imaging findings, and clinical scoring systems to identify high-risk patients earlier. The goal is to avoid unnecessary surgery in patients likely to improve without it, while not delaying surgery in those who need it. This personalized approach could improve outcomes by ensuring each patient receives the right treatment at the right time.

Studies are also investigating optimal nutrition support strategies for patients with chronic or recurrent obstructions. Some trials examine different formulations of enteral nutrition (liquid food delivered through a tube) versus parenteral nutrition (nutrients delivered directly into a vein). Researchers are working to identify which patients benefit most from each approach and how to minimize complications like infections or blood clots that can occur with long-term nutritional support.

For patients with malignant bowel obstruction caused by advanced cancer, clinical trials explore various symptom management strategies. These include different medication combinations to control nausea and pain, as well as techniques for placing intestinal stents that can provide relief when surgery is not an option. Phase II and Phase III trials continue to evaluate these approaches in cancer patients, seeking to improve quality of life when cure is not possible.

Most common treatment methods

  • Conservative management
    • Intravenous fluid resuscitation to correct dehydration and electrolyte imbalances
    • Nasogastric tube decompression to remove trapped gas and fluids from the digestive system
    • Bowel rest with no food or drink by mouth
    • Monitoring for resolution or development of complications
    • Typically continued for up to 72 hours if no signs of serious complications
  • Medication therapy
    • Antibiotics to prevent bacterial translocation and infection
    • Antiemetic medications to control nausea and vomiting
    • Pain medications (avoiding opioids that slow intestinal movement)
    • Prokinetic medications in some cases to stimulate bowel movement
  • Endoscopic procedures
    • Colonoscopic decompression for large bowel obstruction or volvulus
    • Placement of intestinal stents to hold open narrowed areas
    • Water-soluble contrast studies for both diagnosis and potential therapeutic benefit
  • Surgical intervention
    • Open surgery to remove adhesions, repair hernias, or remove tumors
    • Laparoscopic surgery in selected patients for less invasive treatment
    • Bowel resection to remove damaged or dead intestinal tissue
    • Ostomy creation (temporary or permanent) when intestinal reconnection is not possible
    • Required when conservative treatment fails after 48-72 hours or when complications develop
  • Nutritional support
    • Low-fiber, low-residue diet modifications to prevent recurrence
    • Enteral nutrition through feeding tubes for chronic or recurrent cases
    • Parenteral nutrition delivered through intravenous lines when enteral feeding is not possible
    • Gradual diet progression from clear liquids to soft foods after obstruction resolves

Did you know?

  1. About 25% of all emergency department visits for severe, sudden abdominal pain are due to intestinal obstruction, making it one of the most common surgical emergencies worldwide.
  2. Small bowel obstructions were documented as far back as 1550 BC in the Ebers Papyrus, one of the oldest known medical texts, and were described by Hippocrates in ancient Greece—yet the condition still challenges modern medicine.
  3. Approximately 40% of people with colon cancer are first diagnosed when symptoms of bowel obstruction cause them to seek emergency care, making obstruction sometimes the first sign of previously unknown cancer.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Intestinal obstruction

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Peritonitis+3

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alanine
  • Sponsor:Rigshospitalet
See all 1 trials →filters applied: condition = Intestinal obstruction

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).